antimicrobial surgical suture Market

The antimicrobial surgical suture market size is expected to grow from US$ 356.42 million in 2023 to US$ 755.95 million by 2031; it is projected to register a CAGR of 9.9% during 2023-2031.

Antimicrobial surgical sutures are coated or impregnated with chemicals harmful to microorganisms, which interfere with vital cell processes within bacterial cells. Antimicrobial coatings stop bacterial adhesion and growth on suture materials. The rising prevalence of surgical site infections and increasing cases of chronic wounds and surgeries are noteworthy factors contributing to the expansion of the antimicrobial surgical suture market size. However, the noninvasive alternatives to stitches hinder the antimicrobial surgical suture market growth.

The MIT engineers have created "smart" sutures that can not only hold tissues in place but also detect inflammation and provide drugs. The new sutures are made from animal tissue, similar to the "catgut" sutures that were created by the ancient Romans. These sutures are coated with hydrogels that can be integrated with sensors, drugs, or even cells that release therapeutic substances. These sutures could be particularly beneficial for the treatment of Crohn's disease patients who need to undergo colectomy due to excessive scarring or inflammation. Therefore, developments in antimicrobial surgical sutures are likely to bring in new trends in the antimicrobial surgical suture market.

End User -Based Insights

Based on end user, the antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest antimicrobial surgical suture market share in 2023. Hospitals can provide comprehensive care for patients suffering from various ailments, and a maximum number of surgeries are conducted in hospitals. These centers are equipped to handle chronic conditions with complications and emergencies. Antimicrobial sutures are increasingly used in hospitals to reduce the risk of surgical site infections and promote better patient outcomes. The market for antimicrobial surgical sutures in the hospital segment is expected to grow as these healthcare facilities prioritize patient safety and infection prevention measures.

The ambulatory surgical centers segment is expected to register the highest CAGR in the market during 2023-2031. Ambulatory surgical centers perform a significant number of outpatient surgical procedures. Antimicrobial surgical sutures are increasingly being used in ambulatory surgical centers to enhance patient safety and improve surgical outcomes. As these centers continue to grow in popularity for minor surgical procedures, the market for antimicrobial surgical sutures in this segment is expected to expand as well in the coming years. The awareness of the benefits of using antimicrobial sutures to prevent surgical site infections and promote faster healing is growing significantly among healthcare providers in ambulatory surgical centers.

Centers for Disease Control and Prevention, the American College of Surgeons, and the National Library Medicine 2024 report are among the primary and secondary sources referred to while preparing the antimicrobial surgical suture market report.